Secord AA, Lewin SN, Murphy CG, Cecere SC, et al. The Efficacy and Safety of Mirvetuximab Soravtansine in FRalpha-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial. Ann Oncol 2024 Nov 29:S0923-7534(24)04948-2. doi: 10.1016/j.annonc.2024.
PMID: 39617145